These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2089048)

  • 1. Michaelis-Menten pharmacokinetics of phenytoin in adult Malaysian patients.
    Ismail R; Rahman AF
    J Clin Pharm Ther; 1990 Dec; 15(6):411-7. PubMed ID: 2089048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of phenytoin in routine clinic patients in Malaysia.
    Ismail R; Rahman AF; Chand P
    J Clin Pharm Ther; 1994 Aug; 19(4):245-8. PubMed ID: 7989403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenytoin Michaelis-Menten pharmacokinetics in Saudi patients.
    el-Sayed YM; Islam SI
    Int J Clin Pharmacol Ther Toxicol; 1989 Apr; 27(4):173-8. PubMed ID: 2714918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of phenytoin from routine clinical data in Japan.
    Yukawa E; Higuchi S; Aoyama T
    J Clin Pharm Ther; 1989 Feb; 14(1):71-7. PubMed ID: 2921305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [NONMEM approach for estimating population pharmacokinetic parameters of phenytoin in Chinese epileptics].
    Rui JZ; Cai MH; Chu XM; Chen G
    Yao Xue Xue Bao; 1995; 30(3):172-8. PubMed ID: 7639079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing the population pharmacokinetic parameters of phenytoin in adult epileptic patients in South Africa.
    Valodia P; Seymour MA; Miller R; McFadyen ML; Folb PI
    Ther Drug Monit; 1999 Feb; 21(1):57-62. PubMed ID: 10051055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of phenytoin in Singapore Chinese.
    Chan E; Ti TY; Lee HS
    Eur J Clin Pharmacol; 1990; 39(2):177-81. PubMed ID: 2253670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of phenytoin from routine clinical data in Japan: an update.
    Yukawa E; Higuchi S; Aoyama T
    Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):1973-6. PubMed ID: 2268899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose adjustment of phenytoin for comedication in Japanese patients with epilepsy.
    Fukuoka N; Uno J; Tsukamoto T; Houchi H; Kimura M; Morita S
    Ther Drug Monit; 2009 Feb; 31(1):57-62. PubMed ID: 19077928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenytoin Michaelis-Menten pharmacokinetics in Caucasian paediatric patients.
    Bauer LA; Blouin RA
    Clin Pharmacokinet; 1983; 8(6):545-9. PubMed ID: 6653035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenytoin dosage adjustment in Saudi epileptics: utilization of steady-state pharmacokinetic parameters.
    Abduljabbar M; Al-Khamis K; Ogunniyi A; Daif AK; Al-Yamani M
    Eur J Neurol; 1999 May; 6(3):331-4. PubMed ID: 10210914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state pharmacokinetics of phenytoin from routinely collected patient data.
    Grasela TH; Sheiner LB; Rambeck B; Boenigk HE; Dunlop A; Mullen PW; Wadsworth J; Richens A; Ishizaki T; Chiba K
    Clin Pharmacokinet; 1983; 8(4):355-64. PubMed ID: 6617043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of phenytoin in Japanese patients with epilepsy: analysis with a dose-dependent clearance model.
    Odani A; Hashimoto Y; Takayanagi K; Otsuki Y; Koue T; Takano M; Yasuhara M; Hattori H; Furusho K; Inui K
    Biol Pharm Bull; 1996 Mar; 19(3):444-8. PubMed ID: 8924916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three Michaelis-Menten pharmacokinetic dosing methods compared with physician dosing of phenytoin in an outpatient neurology practice.
    Spruill WJ; Wade WE; Cobb HH; Akbari S
    Pharmacotherapy; 2001 Nov; 21(11):1407-14. PubMed ID: 11714214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of bioavailability on the calculated Michaelis-Menten parameters of phenytoin in children.
    Koren G; Brand N; MacLeod SM
    Ther Drug Monit; 1984; 6(1):11-4. PubMed ID: 6710554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenytoin age-dose-concentration relationship in children.
    Suzuki Y; Mimaki T; Cox S; Koepke J; Hayes J; Walson PD
    Ther Drug Monit; 1994 Apr; 16(2):145-50. PubMed ID: 8009561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between phenytoin pharmacokinetics and the CYP2C19 genotype in Japanese epileptic patients.
    Watanabe M; Iwahashi K; Kugoh T; Suwaki H
    Clin Neuropharmacol; 1998; 21(2):122-6. PubMed ID: 9579299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of enzyme or binding constants using generalized linear models, with particular reference to Michaelis-Menten models.
    van Belle G; Leurgans S; Friel P; Guo SW; Yerby M
    J Pharm Sci; 1989 May; 78(5):413-6. PubMed ID: 2746480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenytoin--allopurinol interaction: Michaelis--Menten kinetic parameters of phenytoin with and without allopurinol in a child with Lesch--Nyhan syndrome.
    Yokochi K; Yokochi A; Chiba K; Ishizaki T
    Ther Drug Monit; 1982; 4(4):353-7. PubMed ID: 7157458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Population kinetic program for Michaelis-Menten elimination].
    Lü M; Zhou HW; Song JF
    Zhongguo Yao Li Xue Bao; 1990 Jan; 11(1):85-8. PubMed ID: 2403022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.